Tumor Vessel Normalization, Immunostimulatory Reprogramming, and Improved Survival in Glioblastoma with Combined Inhibition of PD-1, Angiopoietin-2, and VEGF

Di Tacchio, Mariangela; Macas, Jadranka; Weissenberger, Jakob; Sommer, Kathleen; Baehr, Oliver; Steinbach, Joachim P.; Senft, Christian; Seifert, Volker; Glas, Martin; Herrlinger, Ulrich; Krex, Dietmar; Meinhardt, Matthias; Weyerbrock, Astrid; Timmer, Marco; Goldbrunner, Roland; Deckert, Martina; Scheel, Andreas H.; Buettner, Reinhard; Grauer, Oliver M.; Schittenhelm, Jens; Tabatabai, Ghazaleh; Harter, Patrick N.; Guenther, Stefan; Devraj, Kavi; Plate, Karl H.; Reiss, Yvonne

Tumor Vessel Normalization, Immunostimulatory Reprogramming, and Improved Survival in Glioblastoma with Combined Inhibition of PD-1, Angiopoietin-2, and VEGF

Autor(en):

Di Tacchio, Mariangela; Macas, Jadranka; Weissenberger, Jakob; Sommer, Kathleen; Baehr, Oliver; Steinbach, Joachim P.; Senft, Christian; Seifert, Volker; Glas, Martin; Herrlinger, Ulrich; Krex, Dietmar; Meinhardt, Matthias; Weyerbrock, Astrid; Timmer, Marco; Goldbrunner, Roland; Deckert, Martina; Scheel, Andreas H.; Buettner, Reinhard; Grauer, Oliver M.; Schittenhelm, Jens; Tabatabai, Ghazaleh; Harter, Patrick N.; Guenther, Stefan; Devraj, Kavi; Plate, Karl H.; Reiss, Yvonne

Tübinger Autor(en):

Schittenhelm, Jens Florian
Tabatabai, Ghazaleh

Erschienen in:

Cancer Immunology Research (2019), Bd. 7, H. 12, S. 1910-1927

Verlagsangabe:

Amer Assoc Cancer Research

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1158/2326-6066.CIR-18-0865

ISSN:

2326-6074